Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, and healing and repair. Its products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. The company's products include ORTHOVISC, which is an HA product used in the treatment of osteoarthritis in humans; Hyvisc, used for the treatment of equine osteoarthritis; INCERT, which is an HA based anti-adhesive for surgical applications; and AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel, each an injectable ophthalmic viscoelastic HA product. Its products under development include ELEVESS, an HA based dermal filler used for cosmetic tissue augmentation applications and next generation osteoarthritis/joint health related products. Anika Therapeutics sells its products through representatives, agents, and distributors in the United States, Europe, Turkey, and other countries. It has a license and development agreement with Galderma Pharma S.A. development and commercialization of cosmetic dermatology products. The company was founded in 1983 and is headquartered in Woburn, Massachusetts.